Ipsen (United States)
Ipsen is a French biopharmaceutical company headquartered in Paris, France, with a focus on drug development and commercialization in three therapeutic areas: oncology, rare diseases and neuroscience. Ipsen is one of the world's top 15 biopharmaceutical companies in terms of oncology sales. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Ipsen (United States), United States, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
45%
Total
Publications
357
Total Open
Publications
162
Total
Citations
5.7K
Open Access
Percentage
45%
Total
Publications
357
Total Open
Publications
162
Total
Citations
5.7K
Breakdown
Publisher Open
16%
Both
25%
Other Platform Open
3%
Closed
56%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 33%
48
Hybrid 49%
72
No Guarantees 18%
26
Other Platform Open
Domain 81%
84
Institution 27%
28
Other Internet 8%
8
Public 4%
4
Preprint 0%
0
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 85 |
Europe PMC | Domain | 7 |
DOI | Other Internet | 7 |
Academy of Humanities and Economics in Lodz - Homo Politicus | Institution | 5 |
Le Centre pour la Communication Scientifique Directe - HAL - Diderot | Institution | 4 |
Digital Access to Libraries | Institution | 4 |
King's College London - Research Portal | Institution | 3 |
Figshare | Public | 3 |
Université Libre de Bruxelles - Dépôt institutionnel de l'Université libre de Bruxelles | Institution | 2 |
RISalud Institutional Health Repository of Andalucía | Institution | 2 |